Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001999371-25-011273·CureVac N.V.
Schedule 13D ownership disclosure
CUREVAC N V
Common Shares, par value (euro) 0.12 per share · CUSIP: N2451R105
Event date: 2025-08-07
- Filing-level shares
- 16,591,937.00
- Percent of class
- 74%
- GSK plcReported CIK 0001131399
Shares: 16,591,937.00 · Class: 74%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001999371-25-011273
- Form type
- SCHEDULE 13D
- Filer
- CureVac N.V.
- CIK
- CIK 1809122
- Filed
- Aug 13, 2025
- Reporting period
- Aug 07, 2025
- Description
- Schedule 13D beneficial ownership